Advancing Biotherapeutic Treatment of Ulcerative Colitis Using Lipid Mesophases: Formulation Design and Preclinical Validation

Rafaela Gazzi, Tiziana Cremona, Reto Czekalla, Emily Campbell, Marlene Schwarzfischer, Doris Pöhlmann, Vanessa Dobernig, Gerhard Rogler, Michael Scharl, Alessandra Bergadano, Raffaele Mezzenga, Martin Kuentz, Paola Luciani, Simone Aleandri · 2026

Read Advancing Biotherapeutic Treatment of Ulcerative Colitis Using Lipid Mesophases: Formulation Design and Preclinical Validation by Rafaela Gazzi, Tiziana Cremona, Reto Czekalla, Emily Campbell, Marlene Schwarzfischer, Doris Pöhlmann, Vanessa Dobernig, Gerhard Rogler, Michael Scharl, Alessandra Bergadano, Raffaele Mezzenga, Martin Kuentz, Paola Luciani, Simone Aleandri (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13655260.txt.

Description

Rafaela Gazzi and co-authors developed a local delivery system in 2026 for a biologic drug used in ulcerative colitis. Such drugs give high remission in severe disease but bring side effects, complex dosing, and low patient compliance. Since the disease is local to the colon, local delivery is attractive.

The team packed the antibody drug into lipid gel phases that stick to mucus and shield proteins from breakdown. Forms included a rectal gel and oral capsules, some made by 3D printing, that target the colon. Tests showed strong mucus sticking and good colon targeting. In an animal prevention setting, the local forms slowed disease better than injected drug.

Catalog record

CREATORRafaela Gazzi, Tiziana Cremona, Reto Czekalla, Emily Campbell, Marlene Schwarzfischer, Doris Pöhlmann, Vanessa Dobernig, Gerhard Rogler, Michael Scharl, Alessandra Bergadano, Raffaele Mezzenga, Martin Kuentz, Paola Luciani, Simone Aleandri
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE93 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13655260

Browse the full library · About the Tower of Babel